Advanced Medical Solutions ( (GB:AMS) ) has provided an update.
Advanced Medical Solutions Group plc announced that its issued share capital as of March 31, 2025, consists of 217,994,699 ordinary shares with voting rights, with no shares held in treasury. This information is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure and Transparency Rules, impacting how they manage their interests in the company.
More about Advanced Medical Solutions
Advanced Medical Solutions Group plc (AMS) is a leading independent developer and manufacturer of innovative tissue-healing technologies. The company focuses on providing quality outcomes for patients and value for payers through a diverse range of surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants. AMS markets these products under various brands and also supplies wound care dressings. The company operates globally, with manufacturing and R&D hubs across multiple countries, and has made several strategic acquisitions to enhance its product offerings.
YTD Price Performance: 19.94%
Average Trading Volume: 798,968
Technical Sentiment Signal: Sell
Current Market Cap: £508.1M
Learn more about AMS stock on TipRanks’ Stock Analysis page.